U.S. Markets open in 7 hrs 36 mins

Durham's Dova eliminates 39 percent of its US sales force amid strategy shift

Seth Thomas Gulledge
Durham's Dova eliminates 39 percent of its US sales force amid strategy shift

Soon after an executive shake-up at Durham-based Dova Pharmaceuticals, its new CEO says the company has reduced its sales force and discontinued some trials in an effort to double-down on its lead product.